Advocacy Actions

2017-02-28 > Beijing

Meeting with Bureau of Administration of NGOs, MCA

Secretary General of the Chamber received officials from the Bureau of Administration of NGOs, Ministry of Civil Affairs and had a meeting with them.

Read more
2017-02-28 > Beijing

Comments to China Food and Drug Administration (CFDA) on Detailed Regulations on the Examination of Production Licensing of Food for Special Medical Purpose

The European Chamber submitted collated comments to China Food and Drug Administration (CFDA) on Detailed Regulations on the Examination of Production Licensing of Food for Special Medical Purpose.

Read more
2017-02-24 > Beijing

Meeting with Vice Administrator of the CAAC

President Wuttke led a delegation and had a meeting with Vice Administrator Wang Zhiqing of the Civil Aviation Administration of China, CAAC.

Read more
2017-02-24 > Shanghai

Meeting with Italian President S.E. Sergio Mattarella

Meeting with Italian president S.E. Sergio Mattarella during his visit in Shanghai.

Read more
2017-02-24 > Beijing, South China

Meeting with Shenzhen HFPC on Bundled Hospital Payment

The Healthcare Equipment Working Group met with the Vice Director of the Health and Family Planning Commission of Shenzhen Municipality (Shenzhen HFPC) to discuss the effects of the recently introduced bundled payment of medical services at Shenzhen hospitals.

Read more
2017-02-24 > Shanghai

Meeting with the Italian President S.E. Sergio Mattarella

Met Italian President and introduced him our Chamber and our work.

Read more
2017-02-23 > All chapters

Lobby Letter to CFDA on Drug Renaming and Impact on Reimbursement

Lobby Letter to CFDA on Drug Renaming and Impact on Reimbursement

Read more
2017-02-22 > Shanghai

Meeting with Vice President of Zhejiang Institute of Standardization on Future Cooperation

European Chamber Shanghai Chapter met with Vice President of Zhejiang Institute of Standardization on future cooperation.

Read more
2017-02-20 > Beijing

Comments to China Food and Drug Administration (CFDA) on Technical Guidelines for Labeling Specification in the Registration of Recipes of Infant and Young Children Formula (Trial Edition)

The European Chamber submitted collated comments to China Food and Drug Administration (CFDA) on Technical Guidelines for Labeling Specification in the Registration of Recipes of Infant and Young Children Formula (Trial Edition).

Read more
2017-02-20 > Beijing

Comments to China Food and Drug Administration (CFDA) on Technical Guidelines for the Stability Study in Formula Registration of Infant Formula Milk Powder (Trial Edition)

The European Chamber submitted collated comments to China Food and Drug Administration (CFDA) on Technical Guidelines for the Stability Study in Formula Registration of Infant Formula Milk Powder (Trial Edition) .

Read more